Prix Galien 2015, U.S.A.

October 28, 2015

The awarding ceremony of Prix Galien U.S.A. was held at the American Museum of Natural History and the prizes were awarded as following:

• ibrutinib (IMBRUVICA®, Janssen Biotech, Inc. & Pharmacyclics LLC and Abbvie)
• nivolumab (OPDIVO®, Bristol-Myers Squibb)
• pembrolizumab (KEYTRUDA®, Merck & Co)
• T2Candida Panel – T2 Biosystems, Inc.

For more information please contact Mr. Michael Francoeur Makovsky, francoeur@makovsky.com